desloratadine has been researched along with Obesity in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Alpini, GD; Alpini, SF; Du, C; Francis, H; Gashev, AA; Gasheva, OY; Gobbell, C; Hargrove, L; Hitt, AR; Meininger, CJ; Newell-Rogers, MK; Pal, S; Troyanova-Wood, M; Tsoy Nizamutdinova, I; Yakovlev, VV; Zawieja, DC | 1 |
1 other study(ies) available for desloratadine and Obesity
Article | Year |
---|---|
Prolonged intake of desloratadine: mesenteric lymphatic vessel dysfunction and development of obesity/metabolic syndrome.
Topics: Adipose Tissue; Animals; Fatty Liver; Insulin Resistance; Lipids; Loratadine; Lymphatic Vessels; Male; Metabolic Syndrome; Obesity; Rats; Rats, Sprague-Dawley; Weight Gain | 2019 |